Serina Therapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
SER on NYSE
Industry
Pharmaceutical Preparations
Location
601 Genome Way, Suite 2001, Huntsville, AL

Insiders trading volume in the past year

Serina Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Juvenescence Ltd 10%+ Owner $60.3M Jun 6, 2024
Juvenescence US Corp. Director, 10%+ Owner $9.7M Mar 14, 2023
Gregory Bailey Director $4.26M +$17.7K +0.42% Nov 7, 2025
Steven A. Ledger Chief Executive Officer, Director $957K Mar 28, 2025
Jay Venkatesan Director $500K Nov 7, 2025
Steven Mintz Director $247K Sep 12, 2024
Tacey Viegas COO and Secretary $34.6K Mar 26, 2024
Michael D. West Chief Executive Officer $24.8K Mar 11, 2023
Randall Moreadith Chief Scientific Officer $0 -$785K -100% Nov 18, 2025
Andrea Eun Jae Park Chief Financial Officer Jun 4, 2021
Remy Gross Director Apr 1, 2024
Milton Harris Director Apr 1, 2024
Annalisa Jenkins Director Jun 21, 2021
Nafees Malik Chief Operating Officer Jun 4, 2021
Hal Sternberg Vice President-Research Jun 4, 2021
Michael H. May Director Jun 21, 2021
Joanne M. Hackett Director Feb 2, 2022
Judith Segall Director of Admin & Secretary Jun 4, 2021
Jean-Christophe Renondin Director Aug 9, 2023
Marshall Richard Peter Director Nov 7, 2025
Gregory S. Curhan Chief Financial Officer Aug 15, 2024
Stephen K. Brannan Director Nov 7, 2025
Srini Tenjarla SVP, CMC & Formulation Jul 15, 2024
Simba Gill Director Apr 15, 2024
Karen J. Wilson Director Nov 7, 2025

Recent Insider Transactions by Companies or Individuals for Serina Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.